11![Volume[removed]Senior Editor: Barbara Cadario, B.Sc.(Hon), B.Sc.Phm., M.Sc. Junior Editor: Karen L.A. Wlock, B.Sc.(Pharm.) This edition edited by: B. Cadario Volume[removed]Senior Editor: Barbara Cadario, B.Sc.(Hon), B.Sc.Phm., M.Sc. Junior Editor: Karen L.A. Wlock, B.Sc.(Pharm.) This edition edited by: B. Cadario](https://www.pdfsearch.io/img/b5bfadabd3d554e278e73edd0527cd45.jpg) | Add to Reading ListSource URL: dpic.orgLanguage: English - Date: 2014-11-10 15:46:27
|
---|
12![Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl Pharmaceuticals and Medical Devices Agency This English version is intended to be a reference material to provide convenience for users. In the event of inconsistency between the Japanese original and this English transl](https://www.pdfsearch.io/img/aaed1a2d4034252a5b06dc4066784050.jpg) | Add to Reading ListSource URL: www.pmda.go.jpLanguage: English - Date: 2014-11-20 01:17:33
|
---|
13![Published by Ministry of Health, Labour and Welfare Translated by Pharmaceuticals and Medical Devices Agency Published by Ministry of Health, Labour and Welfare Translated by Pharmaceuticals and Medical Devices Agency](https://www.pdfsearch.io/img/613b4a15ae6f7c5e45ad6758cd8823f6.jpg) | Add to Reading ListSource URL: www.pmda.go.jpLanguage: English - Date: 2014-11-20 01:17:33
|
---|
14![Guidelines Guidelines & Protocols & Protocols Advisory Advisory Guidelines Guidelines & Protocols & Protocols Advisory Advisory](https://www.pdfsearch.io/img/65e7c3cf7abe8246554cd1213f606dd7.jpg) | Add to Reading ListSource URL: www.bcguidelines.caLanguage: English - Date: 2014-09-23 17:41:54
|
---|
15![Updates to the Alberta Human Services Drug Benefit Supplement Effective November 1, 2014
Inquiries should be directed to: Updates to the Alberta Human Services Drug Benefit Supplement Effective November 1, 2014
Inquiries should be directed to:](https://www.pdfsearch.io/img/8609b0d400f3812647a1be85ef074521.jpg) | Add to Reading ListSource URL: www.ab.bluecross.caLanguage: English - Date: 2014-11-24 17:45:45
|
---|
16![Updates to the Alberta Human Services Drug Benefit Supplement Effective August 1, 2014
Inquiries should be directed to: Updates to the Alberta Human Services Drug Benefit Supplement Effective August 1, 2014
Inquiries should be directed to:](https://www.pdfsearch.io/img/0ae163dbb2c1dde49fb884b167835560.jpg) | Add to Reading ListSource URL: www.ab.bluecross.caLanguage: English - Date: 2014-07-25 18:04:21
|
---|
17![Ontario Drug Benefit Formulary/Comparative Drug Index Ontario Drug Benefit Formulary/Comparative Drug Index](https://www.pdfsearch.io/img/8bc0ab5960e34ccd8745bdd68d7886cd.jpg) | Add to Reading ListSource URL: www.health.gov.on.caLanguage: English - Date: 2014-09-17 13:39:55
|
---|
18![Alzheimer’s Disease Medications FA C T S H E E T S everal prescription drugs are Alzheimer’s Disease Medications FA C T S H E E T S everal prescription drugs are](https://www.pdfsearch.io/img/282d7f9b0525e9f6696ef6165a24962c.jpg) | Add to Reading ListSource URL: www.nia.nih.govLanguage: English - Date: 2014-02-12 09:40:42
|
---|
19![NOVA SCOTIA PROVINCIAL PHARMACARE PROGRAMS Request for Renewal of a Cholinesterase Inhibitor Please provide the following to support your request for renewal of a cholinesterase inhibitor PATIENT INFORMATION PATIENT SURN NOVA SCOTIA PROVINCIAL PHARMACARE PROGRAMS Request for Renewal of a Cholinesterase Inhibitor Please provide the following to support your request for renewal of a cholinesterase inhibitor PATIENT INFORMATION PATIENT SURN](https://www.pdfsearch.io/img/c3aa52a43cefe6dfa51893917d3a41ef.jpg) | Add to Reading ListSource URL: novascotia.caLanguage: English - Date: 2013-10-09 13:42:26
|
---|
20![HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NAMENDA safely and effectively. See full prescribing information for NAMENDA. ------------------------CONTRAINDICAT HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NAMENDA safely and effectively. See full prescribing information for NAMENDA. ------------------------CONTRAINDICAT](https://www.pdfsearch.io/img/31e0e078b48eaf5c1024760cab429b33.jpg) | Add to Reading ListSource URL: www.frx.comLanguage: English |
---|